Homepage
WuXi Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic
AACR Poster: Armoring CAR-T Therapy with PD-1 Blockade
Learn how inclusion of a PD-1 immune checkpoint blockade protein can overcome PD-L1 mediated CAR-T inhibition
Publication: DNA-Compatible Cyclization Reaction
Learn about new methods to form 1,3,4-oxadiazoles and 1,2,4-triazoles, as superior starting points for the development of bioavailable drugs
On-Demand Webinar: Rare Disease Therapeutics
Learn about important trends in rare disease therapeutics and approaches for accelerating the drug discovery and development process
White Paper: Drug Discovery Strategies for Targeted Protein Degradation
Learn how how DNA-encoded library (DEL) technology can be used for the direct discovery of proteolysis-targeting chimeras
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Our world-class discovery platform is backed by nearly 3000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Latest Presentation
Orthotopic and Metastasis Tumor Models in Rats
Orthotopic and Metastasis Tumor Models in Rats
VIEW PresentationSyngeneic Tumor Models with Resistance Mechanisms to PD-1 Blockade
VIEW PosterLatest Poster
Armoring CAR-T Therapy with PD-1 Blockade
Armoring CAR-T Therapy with PD-1 Blockade
VIEW PosterLatest Publication
Heme Oxygenase-1-Targeting Molecules
Heme Oxygenase-1-Targeting Molecules
VIEW PublicationPeptides for Oligonucleotide Delivery - OPT Congress 2024 Poster
VIEW PosterCovalent Warhead and DEL-Generated Hit Fragmentation
VIEW Poster